| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.19 | 0.0008 |